全文获取类型
收费全文 | 225960篇 |
免费 | 20084篇 |
国内免费 | 7693篇 |
专业分类
耳鼻咽喉 | 1708篇 |
儿科学 | 4267篇 |
妇产科学 | 3028篇 |
基础医学 | 33343篇 |
口腔科学 | 3959篇 |
临床医学 | 17811篇 |
内科学 | 43964篇 |
皮肤病学 | 2948篇 |
神经病学 | 15471篇 |
特种医学 | 4556篇 |
外国民族医学 | 52篇 |
外科学 | 15347篇 |
综合类 | 31010篇 |
现状与发展 | 23篇 |
一般理论 | 8篇 |
预防医学 | 11496篇 |
眼科学 | 2723篇 |
药学 | 34576篇 |
65篇 | |
中国医学 | 9698篇 |
肿瘤学 | 17684篇 |
出版年
2024年 | 196篇 |
2023年 | 4040篇 |
2022年 | 5171篇 |
2021年 | 10271篇 |
2020年 | 8931篇 |
2019年 | 7642篇 |
2018年 | 7425篇 |
2017年 | 7437篇 |
2016年 | 7742篇 |
2015年 | 8823篇 |
2014年 | 13672篇 |
2013年 | 15700篇 |
2012年 | 13368篇 |
2011年 | 15250篇 |
2010年 | 12650篇 |
2009年 | 12843篇 |
2008年 | 12456篇 |
2007年 | 11417篇 |
2006年 | 10162篇 |
2005年 | 8951篇 |
2004年 | 7504篇 |
2003年 | 6597篇 |
2002年 | 5310篇 |
2001年 | 4512篇 |
2000年 | 3747篇 |
1999年 | 3235篇 |
1998年 | 2699篇 |
1997年 | 2586篇 |
1996年 | 2319篇 |
1995年 | 2375篇 |
1994年 | 2128篇 |
1993年 | 1843篇 |
1992年 | 1574篇 |
1991年 | 1463篇 |
1990年 | 1229篇 |
1989年 | 1068篇 |
1988年 | 1038篇 |
1987年 | 857篇 |
1986年 | 780篇 |
1985年 | 1124篇 |
1984年 | 1086篇 |
1983年 | 712篇 |
1982年 | 793篇 |
1981年 | 616篇 |
1980年 | 562篇 |
1979年 | 428篇 |
1978年 | 293篇 |
1977年 | 244篇 |
1976年 | 226篇 |
1975年 | 144篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
目的 测定儿童1型糖尿病(T1DM)患者骨密度(BMD),分析探讨骨密度变化的影响因素。方法 选取于2018年1月—2021年6月于我院收治的儿童1型糖尿病患者76例,收集性别、年龄、发病年龄、身高、体重、BMI、病程等基本资料,检测空腹血糖、空腹C肽、糖化血红蛋白(HbA1c)、血碳酸氢根(HCO3-)、血清碱性磷酸酶(ALP),应用双能X线吸收测定法测定骨密度,获取Z值。结果 76例儿童1型糖尿病患者骨密度Z值为-0.93±2.14。HbA1c、病程与骨密度Z值呈负相关,差异具有统计学意义(分别B=-0.334,P<0.001;B=-0.191,P=0.017)。结论 儿童1型糖尿病患者骨密度低于健康儿童,血糖控制不良、病程长是1型糖尿病儿童骨密度减低的危险因素。 相似文献
82.
《Saudi Pharmaceutical Journal》2022,30(2):108-111
Linezolid is an oxazolidinone antibiotic. Linezolid-associated lactic acidosis has been reported in 6.8% of linezolid-treated patients. Lactic acidosis is associated with poor clinical outcomes, with high blood lactate levels resulting in organ dysfunction and mortality. This case report describes the development of lactic acidosis in a 64-year-old Chinese woman who had received 33 days of treatment with antituberculosis drugs and 28 days of treatment with oral linezolid for tuberculous meningitis. Severe lactic acidosis was reversed by withdrawing antituberculosis drugs and using continuous venovenous hemodiafiltration (CVVH). When the patient's condition was stable, she was transferred to the infectious disease department, and antituberculosis drugs, with the exception of linezolid, were reintroduced. This did not result in recurrence of lactic acidosis. The causal relationship between lactic acidosis and linezolid was categorized as ‘probable’ on the Adverse Drug Reaction Probability Scale. This case demonstrates that CVVH has potential as an alternative to discontinuation of linezolid alone for rapid reversal of linezolid-associated severe lactic acidosis. 相似文献
84.
《Clinical genitourinary cancer》2022,20(6):594-602
The management of patients with metastatic hormone-sensitive prostate cancer (mHSPC) has been significantly modified by the availability of innovative but expensive treatments, increasing the economic burden of prostate cancer. Here, we aimed to systematically identify and review published economic evaluations (EEs) related to the treatment of mHSPC and assess their quality. A systematic search was performed of the PubMed and Cochrane databases. Three reviewers independently selected EEs by defined inclusion and exclusion criteria. They extracted all data from each EE (general information, study population, data about the EE, interventions and comparators, and outcomes). They also assessed the quality of the selected EEs according to Drummond's checklist. Fourteen EEs published between 2016 and 2021 were eligible for the systematic review. The EEs found ADT + docetaxel to be the most cost-effective of all available treatments as a first-line strategy for mHSPC (abiraterone acetate plus prednisone, enzalutamide, and apalutamide). Five EEs showed that a simple price reduction of abiraterone acetate of 50% to 75% could change the results to render this treatment also cost-effective relative to that with docetaxel. Twelve EEs were of high quality, with a Drummond score ≥ 7. Analysis of the 14 EEs identified by our systematic review, amongst which 78.6% met high quality standards, showed that ADT + docetaxel tends to be the most cost-effective alternative for mHSPC. These results were assessed by sensitivity analysis. The data provided by this systematic review help to provide a better understanding of these treatments and the better use of healthcare resources. 相似文献
85.
86.
《Research in social & administrative pharmacy》2022,18(9):3694-3698
In this paper, we argue that understanding and addressing the problem of poor-quality medical products requires a more interdisciplinary approach than has been evident to date. While prospective studies based on rigorous standardized methodologies are the gold standard for measuring the prevalence of poor-quality medical products and understanding their distribution nationally and internationally, they should be complemented by social science research to unpack the complex set of social, economic, and governance factors that underlie these patterns. In the following sections, we discuss specific examples of prospective quality surveys and of social science studies, highlighting the value of cross-sector partnerships in driving high-quality, policy-relevant research in this area. 相似文献
87.
《Clinical breast cancer》2022,22(8):828-839
IntroductionThe potential benefit of systemic therapy in patients with T1a HER2+ cancers is not well understood, and no consensus guidelines exist. We sought to investigate practice patterns of chemotherapy use in this population.MethodsFrom the National Cancer Database (2013-2018), we identified female patients with HER2+ cancers staged as cT1aN0 or pT1aN0 and stratified by receipt of chemotherapy. Using univariate and multivariable analyses we assessed the clinicopathologic features associated with the receipt of chemotherapy. We also compared rates of overall survival (OS).ResultsOf 5176 women with cT1aN0 HER2+ cancers, 88 (2%) received neoadjuvant chemotherapy. Younger age and hormone-receptor (HR) negative tumors were factors independently associated with receipt of neoadjuvant chemotherapy (all P < .001). Of 11,688 women with pT1aN0 HER2+ cancers, 5,588 (48%) received adjuvant chemotherapy. Rates of use increased over the analysis period from 39% in 2013 to 53% in 2018 (P < .001). Factors independently associated with receipt of adjuvant chemotherapy included younger age, having a poorly differentiated tumor, exhibiting lymphovascular invasion, undergoing adjuvant radiation (all P < .001). There were no differences in OS when comparing those who did and did not receive chemotherapy in either group.ConclusionsThe use of chemotherapy in patients with HER2+ T1a cancers is increasing over time and is, as expected, more common among patients with unfavorable clinicopathologic features. Since no prognostic algorithm currently exists, more prospective data is needed to understand which of these patients may derive benefit from systemic therapy and which may safely avoid the morbidity of chemotherapy. 相似文献
88.
89.